
Improving patient prognostication in mantle cell lymphoma informs treatment decisions and enhances our understanding of the disease's biology.
Zachary Epstein-Peterson, MD, is a lymphoma specialist at Memorial Sloan Kettering Cancer Center in New York, NY.

Improving patient prognostication in mantle cell lymphoma informs treatment decisions and enhances our understanding of the disease's biology.